Skip to main content
. 2020 Dec 13;169:168–189. doi: 10.1016/j.addr.2020.12.006

Fig. 3.

Fig. 3

Overview of vector-based SARS-CoV-2 vaccines. [62,[158], [159], [160], [161], [162], [163]], NCT04299724, NCT04334980